1888 PressRelease Home	Sign In	Register	About Us	Sitemap

1888 Press Release | Intas Biopharmaceuticals Limited Press Releases

Intas Biopharmaceuticals Limited Company News Section

Intas Biopharmaceuticals Limited Information

Siddharth J. Baad

Phone: 00912717660208

Intas Biopharmaceuticals Limited (IBPL) has fully integrated biopharmaceutical operations at Ahmedabad, Gujarat. Since the launch of biotechnology operations in May 2000, Research & Development (R&D) and manufacturing of biopharmaceutical products with a special focus on Oncology (Cancer) are major thrust areas for the company. Being India’s first and only biopharmaceuticals company to receive EUROPEAN UNION – GOOD MANUFACTURING PRACTICE (EU-GMP) certification for its manufacturing facility, IBPL has carved a niche in the biopharmaceutical operations In terms of quality standards, the facility complies with strict international Good Manufacturing Practice regulations and conforms to guidelines laid down by WORLD HEALTH ORGANIZATION (WHO).

Intas Biopharmaceuticals Limited Press Release

01
FEB

Apotex And Intas Biopharmaceuticals Extend Their Collaborative Development Of Biosimilars To Include pegfilgrastim

Apotex Inc. of Canada and Intas Biopharmaceuticals Limited (IBPL) of India have extended their business agreement to develop a biosimilar version of pegfilgrastim, a protein that is used to treat neutropenia (a side effect of cancer chemotherapy).

Neupeg™, a recombinant pegylated granulocyte colony stimulating factor is already manufactured and marketed in India and other countries by IBPL. Both ...

23
JAN

Celestial Biologicals Collaborates With GE Healthcare To Set Up India’s First Fully Integrated Chromatography Based Plasma Fractionation Facility

Major boost to patients with blood/immune disorders or severe blood loss India can save foreign exchange equivalent to INR 250 Crores through local manufacturing of plasma products. Investment of Rs. 100-120 crores to be spread out over the next two years GE Healthcare to provide its leading purification technologies, processes and support.

CELESTIAL BIOLOGICALS LIMITED (CBL), an associated company of Intas Biopharmaceuticals Limited, and GE HEALTHCARE, the US$17 billion healthcare busine ...

20 JAN	IBPL Plans Manufacturing Facility For Monoclonal Antibodies
	Company to invest Rs. 160 crores for recombinant Mammalian platform product; signs MoU with Government of Gujarat at the recently concluded Vibrant Gujarat Global Investors Summit 2009. Intas Biopharmaceuticals Limited, India’s leading biotechnology company, signed a Memorandum of Understanding (MoU) with Government of Gujarat for set ...

07 May	Intas Plans Filgrastim Launch In North America, Europe
	Intas Biopharma is a part of Cooperation between three continents for Biosimilar GCSF. INTAS BIOPHARMACEUTICALS LIMITED (IBPL) signed business agreement with Canada–based APOTEX INC. for co-development and supply of its Filgrastim brand, ...